Coming soon Magic pill
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Twitter ~ Facebook
Home / Technology News / 2010 / October 2010 / October 12, 2010
Coming soon: 'Magic pill' for men with aggressive prostate cancer
RSS / Print / Comments

Sky News

Blow-by-blow account of trapped Chilean miners' rescue plan

Coming soon: 'Magic pill' for men with aggressive prostate cancer

Justin Timberlake defends Mark Zuckerberg over charity donation

More on Sky News

Bono

Coming soon: 'Magic pill' for men with aggressive prostate cancer

Hindus commend French diva Fanny Ardant for highlighting Roma maltreatment

U2 thrill fans by performing Spiderman song

More on Bono

Prostate cancer

Coming soon: 'Magic pill' for men with aggressive prostate cancer

Gender-bending chemical in plastics 'ups prostate cancer risk'

New Data for Erbitux in Prevalent Cancers to Be Revealed at ESMO

More on Prostate cancer

Technology News

Squeezable cell phone to give you status info without having to look at it
Scientists have developed a squeezable cellphone - SqueezeBlock - using tiny motors built into the casing to mimic the behaviour of a spring. ANI

Airplanes that also travel in space to be 'the holy grail' of aeronautics
A British firm is working on an airplane that would also travel in space. ANI

Was Oz-Indian scientist first to discover recently found Earth-like planet?
The recent discovery of Earth-like planet caused a tizzy in the science world, but many are still sceptical of the claim. ANI

Coming soon: 'Magic pill' for men with aggressive prostate cancer

A study from the Institute of Cancer Research based in London and Surrey indicates that a potentially life-prolonging pill for men with aggressive prostate cancer could be available within a year.


London, Oct 12 : A study from the Institute of Cancer Research based in London and Surrey indicates that a potentially life-prolonging pill for men with aggressive prostate cancer could be available within a year.

The abiraterone acetate drug, for which phase three trials were halted on ethical grounds, will offer new hope to men with advanced prostate cancer.

The study has important implications because currently men with this aggressive type of prostate cancer currently have very few treatment options and a poor prognosis.

Risk of death was reduced by 35percent in men receiving abiraterone while survival was increased by 36 percent from a midpoint of 10.9 to 14.8 months.

"The news that abiraterone acetate may extend survival with manageable side-effects will be incredibly important to men with prostate cancer and their families," Sky News quoted study leader Dr Johan de Bono as saying.

Results from the trial have been presented at the European Society for Medical Oncology Congress in Milan, Italy.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us